Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease. 25320178 Fu YP, Kohaar I, Moore LE, Lenz P, Figueroa JD, Tang W, Porter-Gill P, Chatterjee N, Scott-Johnson A, Garcia-Closas M, Muchmore B, Baris D, Paquin A, Ylaya K, Schwenn M, Apolo AB, Karagas MR, Tarway M, Johnson A, Mumy A, Schned A, Guedez L, Jones MA… Cancer Res. 2014 PLCO
Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis. 25360682 Weng PH, Huang YL, Page JH, Chen JH, Xu J, Koutros S, Berndt S, Chanock S, Yeager M, Witte JS, Eeles RA, Easton DF, Neal DE, Donovan J, Hamdy FC, Muir KR, Giles G, Severi G, Smith JR, Balistreri CR, Shui IM, Chen YC PLoS ONE 2014 PLCO
Prediagnostic circulating anti-Müllerian hormone concentrations are not associated with prostate cancer risk. 25159294 Sklavos MM, Zhou CK, Pinto LA, Cook MB Cancer Epidemiol. Biomarkers Prev. 2014 PLCO
Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer. 25178985 Black A, Pinsky PF, Grubb RL, Falk RT, Hsing AW, Chu L, Meyer T, Veenstra TD, Xu X, Yu K, Ziegler RG, Brinton LA, Hoover RN, Cook MB Cancer Epidemiol. Biomarkers Prev. 2014 PLCO
Beyond infectious disease: welcome to the era of population microbiology. 25439278 Pincus MR, Pei Z Clin. Lab. Med. 2014 PLCO
The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis. 25439270 Cho M, Carter J, Harari S, Pei Z Clin. Lab. Med. 2014 PLCO
Microbiome, innate immunity, and esophageal adenocarcinoma. 25439272 Baghdadi J, Chaudhary N, Pei Z, Yang L Clin. Lab. Med. 2014 PLCO
Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets. 24522917 Ma Y, Madupu R, Karaoz U, Nossa CW, Yang L, Yooseph S, Yachimski PS, Brodie EL, Nelson KE, Pei Z J. Virol. 2014 PLCO
Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma. 25126590 Xu W, Yang L, Lee P, Huang WC, Nossa C, Ma Y, Deng FM, Zhou M, Melamed J, Pei Z Am J Clin Exp Urol 2014 PLCO
Microbiome in reflux disorders and esophageal adenocarcinoma. 24855009 Yang L, Chaudhary N, Baghdadi J, Pei Z Cancer J 2014 PLCO
Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 24747429 Nolen BM, Brand RE, Prosser D, Velikokhatnaya L, Allen PJ, Zeh HJ, Grizzle WE, Huang Y, Lomakin A, Lokshin AE PLoS ONE 2014 PLCO
Serum transforming growth factor-β1 and risk of pancreatic cancer in three prospective cohort studies. 24913781 Jacobs EJ, Newton CC, Silverman DT, Nogueira LM, Albanes D, Männistö S, Pollak M, Stolzenberg-Solomon RZ Cancer Causes Control 2014 PLCO
A pooled analysis of body mass index and mortality among African Americans. 25401742 Cohen SS, Park Y, Signorello LB, Patel AV, Boggs DA, Kolonel LN, Kitahara CM, Knutsen SF, Gillanders E, Monroe KR, Berrington de Gonzalez A, Bethea TN, Black A, Fraser G, Gapstur S, Hartge P, Matthews CE, Park SY, Purdue MP, Singh P, Harvey C, Blot … PLoS ONE 2014 PLCO
Human metabolic correlates of body mass index. 25254000 Moore SC, Matthews CE, Sampson JN, Stolzenberg-Solomon RZ, Zheng W, Cai Q, Tan YT, Chow WH, Ji BT, Liu DK, Xiao Q, Boca SM, Leitzmann MF, Yang G, Xiang YB, Sinha R, Shu XO, Cross AJ Metabolomics 2014 PLCO
Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance. 25249326 Kitahara CM, Trabert B, Katki HA, Chaturvedi AK, Kemp TJ, Pinto LA, Moore SC, Purdue MP, Wentzensen N, Hildesheim A, Shiels MS Cancer Epidemiol. Biomarkers Prev. 2014 PLCO
A pooled analysis of body mass index and pancreatic cancer mortality in african americans. 25017247 Bethea TN, Kitahara CM, Sonderman J, Patel AV, Harvey C, Knutsen SF, Park Y, Park SY, Fraser GE, Jacobs EJ, Purdue MP, Stolzenberg-Solomon RZ, Gillanders EM, Blot WJ, Palmer JR, Kolonel LN Cancer Epidemiol. Biomarkers Prev. 2014 PLCO
Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. 24861847 Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K, Patel AV, Adami HO, Weiderpass E, Giles GG, Singh PN, Alavanja M, Beane Freeman LE, Bernstein L, Buring JE, Colditz GA, Fraser GE, Gapstur SM, Gaziano JM, Giovannucci E, Hofmann JN, Li… Br. J. Haematol. 2014 PLCO
Metabolites of tobacco smoking and colorectal cancer risk. 24648381 Cross AJ, Boca S, Freedman ND, Caporaso NE, Huang WY, Sinha R, Sampson JN, Moore SC Carcinogenesis 2014 PLCO
Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. 24552677 Brinton LA, Cook MB, McCormack V, Johnson KC, Olsson H, Casagrande JT, Cooke R, Falk RT, Gapstur SM, Gaudet MM, Gaziano JM, Gkiokas G, Guénel P, Henderson BE, Hollenbeck A, Hsing AW, Kolonel LN, Isaacs C, Lubin JH, Michels KB, Negri E, Parisi D, Pet… J. Natl. Cancer Inst. 2014 PLCO
Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. 24449056 Braganza MZ, Berrington de González A, Schonfeld SJ, Wentzensen N, Brenner AV, Kitahara CM Cancer Prev Res (Phila) 2014 PLCO